ID   CTC44
AC   CVCL_YJ18
DR   cancercelllines; CVCL_YJ18
DR   Wikidata; Q93459984
RX   PubMed=27456153;
CC   Group: Cancer stem cell line.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=27456153).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=27456153).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YJ15 ! CPP44
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 7
//
RX   PubMed=27456153; DOI=10.1136/gutjnl-2016-311447;
RA   Grillet F., Bayet E., Villeronce O., Zappia L., Lagerqvist E.L.,
RA   Lunke S., Charafe-Jauffret E., Pham K.T., Molck C., Rolland N.,
RA   Bourgaux J.-F., Prudhomme M., Philippe C., Bravo S., Boyer J.-C.,
RA   Canterel-Thouennon L., Taylor G.R., Hsu A.L., Pascussi J.-M.,
RA   Hollande F., Pannequin J.;
RT   "Circulating tumour cells from patients with colorectal cancer have
RT   cancer stem cell hallmarks in ex vivo culture.";
RL   Gut 66:1802-1810(2017).
//